CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply

Neeraj Agarwal; Axel S. Merseburger; Svetlana Andrianova; Arun A. Azad

doi:10.1016/S1470-2045(25)00538-8

CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply

Neeraj Agarwal, Axel S. Merseburger, Svetlana Andrianova, Arun A. Azad

Clinic of Urology

Original language	English
Journal	The Lancet Oncology
Volume	26
Issue number	10
Pages (from-to)	e512-e513
ISSN	1470-2045
DOIs	https://doi.org/10.1016/S1470-2045(25)00538-8
Publication status	Published - 10.2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

DFG Research Classification Scheme

2.22-23 Reproductive Medicine, Urology

Access to Document

10.1016/S1470-2045(25)00538-8

Cite this

@article{da652ef957904beaba1bff56ce04d59c,

title = "CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply",

author = "Neeraj Agarwal and Merseburger, \{Axel S.\} and Svetlana Andrianova and Azad, \{Arun A.\}",

year = "2025",

month = oct,

doi = "10.1016/S1470-2045(25)00538-8",

language = "English",

volume = "26",

pages = "e512--e513",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "10",

}

TY - JOUR

T1 - CONTACT-02

T2 - limited clinical benefit and a suboptimal control group – Authors' reply

AU - Agarwal, Neeraj

AU - Merseburger, Axel S.

AU - Andrianova, Svetlana

AU - Azad, Arun A.

PY - 2025/10

Y1 - 2025/10

UR - https://www.scopus.com/pages/publications/105017030629

U2 - 10.1016/S1470-2045(25)00538-8

DO - 10.1016/S1470-2045(25)00538-8

M3 - Letters

C2 - 41038190

AN - SCOPUS:105017030629

SN - 1470-2045

VL - 26

SP - e512-e513

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 10

ER -

CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply

UN SDGs

DFG Research Classification Scheme

Access to Document

Other files and links

Cite this